Learn how to get started on Omvoh first with IV infusions that then transition to self injections. Find dosing and maintenance for using Omvoh to treat UC or Crohn's disease.

Find the Omvoh style guide with brand assets such as logos, colors, fonts, and more.

Omvoh injection is available as a 300mg/15 mL solution in a single-dose vial for intravenous infusion, and as a 100 mg/mL solution or a 200 mg/2 mL solution in a single dose prefilled pen or prefilled syringe for subcutaneous injection.

Some people with ulcerative colitis or Crohn’s disease taking Omvoh experienced rapid symptom relief. Omvoh could help people achieve steroid-free remission at 1 year. * UC improvement seen at week 3 for rectal bleeding and stool frequency. CD improvement seen at week 6 for abdominal pain and week 12 for stool frequency.

The following 15 images provide visual information about the product associated with Omvoh NDC 0002-7722 by Eli Lilly And Company, such as packaging, labeling, and the appearance of the drug itself.

Mar 19, 2025 · Eli Lilly has claimed FDA approval for its IL-23 inhibitor Omvoh as a treatment for moderately to severely active Crohn's disease, extending its use beyond ulcerative colitis (UC) for the first...

OMVOH is a clear to opalescent, colorless to slightly yellow to slightly brown solution available as: • Intravenous Infusion: Injection: 300 mg/15 mL (20 mg/mL) solution in a single-dose vial

View images of OMVOH PEN and identify pills by imprint, color or shape. If you need to save money on your OMVOH PEN, compare our prices. Our prescription savings may even be lower than your insurance copay!

Jan 14, 2025 · Omvoh was approved in 2023 to treat moderate to severe ulcerative colitis in adults. The medicine targets interleukin (IL)-23 and contains the active ingredient mirikizumab-mrkz.

Mar 3, 2025 · Omvoh (mirikizumab) is used to treat adults with inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease. This prescription biologic is given as an IV infusion or a subcutaneous injection, and is effective at managing moderate to severe cases of these chronic inflammatory conditions.